| 000 | 01613 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517224624.0 | ||
| 264 | 0 | _c20190813 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1664-3224 | ||
| 024 | 7 |
_a10.3389/fimmu.2018.01221 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMolina, María | |
| 245 | 0 | 0 |
_aCD19 _h[electronic resource] |
| 260 |
_bFrontiers in immunology _c2018 |
||
| 300 |
_a1221 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntigens, CD19 _xmetabolism |
| 650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 | _aCause of Death |
| 650 | 0 | 4 |
_aComplement System Proteins _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins _xblood |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xblood |
| 650 | 0 | 4 | _aLymphocyte Count |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMortality |
| 650 | 0 | 4 | _aPatient Outcome Assessment |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aRenal Dialysis _xadverse effects |
| 700 | 1 | _aAllende, Luis M | |
| 700 | 1 | _aRamos, Luis E | |
| 700 | 1 | _aGutiérrez, Eduardo | |
| 700 | 1 | _aPleguezuelo, Daniel E | |
| 700 | 1 | _aHernández, Eduardo R | |
| 700 | 1 | _aRíos, Francisco | |
| 700 | 1 | _aFernández, Cristina | |
| 700 | 1 | _aPraga, Manuel | |
| 700 | 1 | _aMorales, Enrique | |
| 773 | 0 |
_tFrontiers in immunology _gvol. 9 _gp. 1221 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3389/fimmu.2018.01221 _zAvailable from publisher's website |
| 999 |
_c28589523 _d28589523 |
||